201 related articles for article (PubMed ID: 19463278)
1. [Micafungin for the treatment of neonatal invasive candidiasis].
Infante-López ME; Rojo-Conejo P
Rev Iberoam Micol; 2009 Mar; 26(1):56-61. PubMed ID: 19463278
[TBL] [Abstract][Full Text] [Related]
2. [Why might micafungin be the drug of choice in pediatric patients?].
Ramos Amador JT; Prieto Tato L; Guillén Martín S
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():23-8. PubMed ID: 21420573
[TBL] [Abstract][Full Text] [Related]
3. [Micafungin in invasive candidiasis among oncohematological patients].
Jarque I; Angel Sanz M
Rev Iberoam Micol; 2009 Mar; 26(1):75-7. PubMed ID: 19463282
[TBL] [Abstract][Full Text] [Related]
4. [Micafungin for therapy of invasive candidiasis in solid organ transplant recipients].
Fortún-Abete J
Rev Iberoam Micol; 2009 Mar; 26(1):65-8. PubMed ID: 19463280
[TBL] [Abstract][Full Text] [Related]
5. [Clinical use of micafungin for the treatment of invasive candidiasis in critical ill patients].
Pozo-Laderas JC
Rev Iberoam Micol; 2009 Mar; 26(1):69-74. PubMed ID: 19463281
[TBL] [Abstract][Full Text] [Related]
6. [Micafungin in pediatric and adolescent patients].
Madero-López L
Rev Iberoam Micol; 2009 Mar; 26(1):62-4. PubMed ID: 19463279
[TBL] [Abstract][Full Text] [Related]
7. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
Salavert-Lletí M; Zaragoza-Crespo R
Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
9. [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
Montejo M; Quindós G
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():15-22. PubMed ID: 21420572
[TBL] [Abstract][Full Text] [Related]
10. The management of Candida infections in preterm neonates and the role of micafungin.
Manzoni P; Benjamin DK; Hope W; Rizzollo S; Del Sordo P; Stronati M; Jacqz-Aigrain E; Castagnola E; Farina D
J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():24-7. PubMed ID: 21749182
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of micafungin in treating four premature infants with candidiasis.
Kawaguchi C; Arai I; Yasuhara H; Sano R; Nishikubo T; Takahashi Y
Pediatr Int; 2009 Apr; 51(2):220-4. PubMed ID: 19405920
[TBL] [Abstract][Full Text] [Related]
12. Echinocandin use in the neonatal intensive care unit.
Caudle KE; Inger AG; Butler DR; Rogers PD
Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
[TBL] [Abstract][Full Text] [Related]
13. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA; Scott LJ
Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
[TBL] [Abstract][Full Text] [Related]
14. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
[TBL] [Abstract][Full Text] [Related]
15. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
Scott LJ
Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856
[TBL] [Abstract][Full Text] [Related]
16. Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials.
Horn DL; Ostrosky-Zeichner L; Morris MI; Ullmann AJ; Wu C; Buell DN; Kovanda LL; Cornely OA
Eur J Clin Microbiol Infect Dis; 2010 Feb; 29(2):223-9. PubMed ID: 20013016
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.
Tsekoura M; Ioannidou M; Pana ZD; Haidich AB; Antachopoulos C; Iosifidis E; Kolios G; Roilides E
Pediatr Infect Dis J; 2019 Jan; 38(1):42-49. PubMed ID: 29596219
[TBL] [Abstract][Full Text] [Related]
18. International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
Ostrosky-Zeichner L; Kontoyiannis D; Raffalli J; Mullane KM; Vazquez J; Anaissie EJ; Lipton J; Jacobs P; van Rensburg JH; Rex JH; Lau W; Facklam D; Buell DN
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):654-61. PubMed ID: 16261306
[TBL] [Abstract][Full Text] [Related]
19. Micafungin - the newest echinocandin.
Temesgen Z; Barreto J; Vento S
Drugs Today (Barc); 2009 Jun; 45(6):469-78. PubMed ID: 19856528
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of micafungin for the treatment of candidemia.
Andes D; Safdar N
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):662-4. PubMed ID: 16247615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
